Cory berkland.

Photo: Bryce Stottlemire, a doctoral student in bioengineering, displays one of the face shields designed and fabricated in the labs of Mei He, assistant professor of chemical & petroleum engineering, and Cory Berkland, Solon E. Summerfield Distinguished Professor of Pharmaceutical Chemistry.Brittany L Hartwell 1 , Chad J Pickens 2 , Martin Leon 3 , Cory Berkland 1 2 4 Affiliations 1 Bioengineering Graduate Program, University of Kansas 1520 West 15th Street, Lawrence, Kansas 66045, United States.Chittasupho C, Sestak J, Shannon L, Siahaan TJ, Vines CM, Berkland C. Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro. Mol Pharm. 2013;11(1):367–73. doi: 10.1021/mp4003909. [Europe PMC free article]The main apparatus (Fig. 1A), which provides fabrication of monodisperse microparticles, is based on passing a solution containing the sphere material, and any drug to be encapsulated, through a small nozzle or other orifice (20 μm to a few millimeters in diameter) to form a smooth, cylindrical jet.To controllably break the jet into droplets, the nozzle is vibrated by a piezoelectric ...

Hyaluronic acid (HA) is a naturally occurring biodegradable polymer with a variety of applications in medicine, including scaffolding for tissue engineering, dermatological fillers and viscosupplementation for osteoarthritis treatment. HA is available in most connective tissues in body fluids such as synovial fluid and the vitreous humor of …Cory Berkland Diabetes is a set of diseases characterized by defects in insulin utilization, either through autoimmune destruction of insulin-producing cells (Type I) or insulin resistance (Type II).

Cory Berkland. 2007, Journal of Pharmaceutical Sciences. Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule delivery requires invasive methods such as frequently repeated injections. Parenteral depots including biodegradable ...

Bond Biosciences has a strong board and managment team with significant industry experience including Cory Berkland, Mike Riley, Tim Opler and Mike Beckloff.Nashwa El-Gendy, Mark M. Bailey, Cory Berkland; Pages 283-312. Liposomes for Pulmonary Drug Delivery. Janani Swaminathan, Carsten Ehrhardt; Pages 313-334. Nanoparticles for Pulmonary Delivery. Alan B. Watts, Robert O. Williams III; Pages 335-366. Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy.Hartwell BL; Pickens CJ; Leon M; Berkland C, Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6), 1893–1907. [PMC free article] [Google Scholar]Burkholderia pseudomallei, the etiological agent responsible for melioidosis, exhibits a great public health toll in its endemic regions. The elevation of B. pseudomallei to a Tier I select agent underscores the urgent need for effective therapeutics and preventatives. The current treatment regimen for melioidosis is suboptimal, requiring an intensive phase of intravenous antibiotic followed ...Fah Chueahongthong; Singkome Tima; Sawitree Chiampanichayakul; Cory Berkland; Songyot Anuchapreeda: 1-Jan-2022 ...

Settimio Pacelli, Sayantani Basu, Cory Berkland, Jinxi Wang and Arghya Paul have no conflicts of interest to disclose. Ethical Approval. This article does not contain any studies with human participants or animals performed by any of the authors. Only commercially obtained cells were used.

Three decades of promise have culminated in the development of gene therapies that can be applied to a broad range of human diseases. After a brief history, we provide an overview of gene therapy types and delivery methods, gene editing technologies, regulatory affairs, clinical trials, approved pro …

Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. He is taking a part ial leave as Distinguished Professor at The University of Kansas to advance the business and to ensure the development and clinical trial progression of BBI-001.Berkland is currently serving as the commander, 354th Fighter Wing, Pacific Air Forces, Eielson Air Force Base, Alaska. Air Force Col. Amy S. Bumgarner for appointment to the grade of brigadier ...Barlas Büyüktimkin, 1 Qun Wang, 2 Paul Kiptoo, 1 John M. Stewart, 1 Cory Berkland, 1, 2 and Teruna J. Siahaan 1, * Barlas Büyüktimkin 1 Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KSCorrespondence to: C. Berkland (e-mail: [email protected])Search for more papers by this author. Amir Fakhari, ... Search for more papers by this author. Cory Berkland, Corresponding Author. Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas.Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile . Jonathan Brumberg, Ph.D.-Associate Professor, Speech-Language-Hearing: Sciences & Disorders-Courtesy Associate Professor, Electrical Engineering & Computer Science;

Novel technologies to enhance therapeutic delivery and biomaterial performance are fundamental to the development of improved products with fewer unwanted side effects. The Therapeutic Particles and Biomaterials Technology Laboratory at The University of Kansas (KS, USA) works at the interface of medicine and engineering to develop novel materials that enhance therapeutic delivery in a variety ...Cory Berkland Professor Berkland has garnered international attention for his seminal research on colloids and materials applied to science. His award is in recognition of a series of closely related research contributions that fundamentally define and apply the phenomena of nanoparticle assembly as a means to emulate naturally occurring ...Todd Berkland Work Experience and Education. According to ZoomInfo records, Todd Berkland`s professional experience began in 2000. Since then Todd has changed 4 companies and 3 roles. Currently, Todd Berkland works as a Vice President, Business Development & Acquisitions at Wrench Group.Cory Berkland, PhD Chief Executive Officer. Dr. Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. …Cory Berkland. Corresponding Author. E-mail address: [email protected]. Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047.Singkome Tima, 1 Siriporn Okonogi, 2 Chadarat Ampasavate, 2 Chad Pickens, 3 Cory Berkland, 3, * and Songyot Anuchapreeda 4, * Singkome Tima 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, Thailand

BERKLAND CORY, WANG QUN. Author information. Affiliations. All authors. 1. UNIV KANSAS Patent: Publ. of Application with search report - European Patent Office Application: EP20080848334 on 06 Nov 2008 Publication: 06 Nov 2008 PAT: EP2217295 . Patent. Share this article ...

Bradley J. Newell. Interim Assistant Dean - Wichita. Director - PGY-1 Community-Based Pharmacy Residency (DIllons) Clinical Assistant Professor. School of Pharmacy - Administration. Department of Pharmacy Practice. Dept. of Family & Community Med., KU Med., Wichita. View full profile.Purpose Encapsulation of liquids into biodegradable polymer microcapsules has been a challenging task due to production limitations stemming from solution viscosity, phase stabilization, molecular localization, and scalable production. We report an extension of Precision Particle Fabrication (PPF) technology for the production of monodisperse …Singkome Tima, 1 Siriporn Okonogi, 2 Chadarat Ampasavate, 2 Chad Pickens, 3 Cory Berkland, 3, * and Songyot Anuchapreeda 4, * Singkome Tima 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, ThailandConflict of interest C. Berkland has a patent (US 20110287547 A1) on Ca-TAT peptides. These studies were not solicited or funded by any pharmaceutical company. ... Cory Berkland, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS …Course Search. Search class sections | Online courses. Library SearchSingkome Tima; Songyot Anuchapreeda; Chadarat Ampasavate; Cory Berkland; Siriporn Okonogi 1-Sep-2008 Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell linesCory Berkland, Ph.D. Co-Founder, President. Nabil Alhakamy, Ph.D. Co-Founder, COO. Danny Griffin, Ph.D. Co-Founder, CSO. Copyright 2022 Kinimmune, Inc. | Legal.Cory Berkland, Ph.D. Date. Friday, January 29, 2021 - 12:00pm. Location. University of Houston. Abstract. Basic principles have emerged for oral and intravenous drug design, but fewer efforts have aimed to create drugs that persist at the administration site or molecular structures thatCory Berkland, Ph.D. Date. Friday, January 29, 2021 - 12:00pm. Location. University of Houston. Abstract. Basic principles have emerged for oral and intravenous drug design, but fewer efforts have aimed to create drugs that persist at the administration site or molecular structures that

Singkome Tima, Songyot Anuchapreeda, Chadarat Ampasavate, Cory Berkland, Siriporn Okonogi. Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells. European Journal of Pharmaceutics and Biopharmaceutics 2017, 114, 57-68. DOI: 10.1016/j.ejpb.2016.12.032.

Complexes were formed by addition of appropriate volumes of pDNA and TAT with or without CaCl 2 (15 μL of 113 mM CaCl 2) or PEI solutions calculated to produce the desired molar ratio, followed by a 20 min incubation at 4 °C prior to use (Baoum and Berkland, 2011). Complexes were freshly prepared before each individual analysis. 2.3.

Bradley J. Newell. Interim Assistant Dean - Wichita. Director - PGY-1 Community-Based Pharmacy Residency (DIllons) Clinical Assistant Professor. School of Pharmacy - Administration. Department of Pharmacy Practice. Dept. of Family & Community Med., KU Med., Wichita. View full profile.Dr. Brian T. Andrews is a Plastic Surgeon in Iowa City, IA. Find Dr. Andrews's phone number, address, insurance information, hospital affiliations and more.Jun 12, 2017 · Brittany L Hartwell 1 , Chad J Pickens 2 , Martin Leon 3 , Cory Berkland 1 2 4 Affiliations 1 Bioengineering Graduate Program, University of Kansas 1520 West 15th Street, Lawrence, Kansas 66045, United States. Purpose Encapsulation of liquids into biodegradable polymer microcapsules has been a challenging task due to production limitations stemming from solution viscosity, phase stabilization, molecular localization, and scalable production. We report an extension of Precision Particle Fabrication (PPF) technology for the production of monodisperse …If delivered as a suspension, such small particles are also prone to particle growth due to Ostwald ripening and can suffer from uncontrolled agglomeration (Berkland, 2010). A major obstacle to inhaled therapeutics is the inability to efficiently deliver large quantities of a drug to the deep lung (Gillian, 2010).J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122.Cory Berkland, The University of Kansas, Lawrence, Kansas, United States of America Akhilesh Bhambhani, Merck and Co Inc West Point, Doylestown, Pennsylvania, United States of America Michael Blaber, Florida State University, Tallahassee, Florida, United States of AmericaAbdulgader Baoum, 1 Sheng-Xue Xie, 1 Amir Fakhari, 2 and Cory Berkland 1, 3, 4 Abdulgader Baoum 1 Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USAPulmonary delivery of vancomycin dry powder aerosol to intubated rabbits Bradley P. Sullivan1,#, Nashwa El-Gendy1,3,#, Christopher Kuehl1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas, 66047 2Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas, 66045 3Department of Pharmaceutics and Industrial ...Cory J Berkland. Department of Chemical and Petroleum Engineering, University of Kansas, USA. Department of Pharmaceutical Chemistry, University of Kansas ...Introduction. Hollow particles, also referred to as capsules or vesicles, are generating interest in industry as well as scientific research. Many active ingredients have been formulated within a capsule core to protect them from the surrounding environment and/or to facilitate sustained release including; adhesives, agrochemicals, catalysts, living cells, flavor oils, pharmaceuticals ...01‏/02‏/2010 ... ... Cory Berkland, Ph.D., who, with George Laurence, invented the company's NanoCluster technology in his laboratory at the University of Kansas ...

A Few Early Lessons in Entrepreneurship. Cory Berkland, Ph.D. Friday, September 1, 2017. 1:30 P.M.. Rawl Engineering Practice Facility, Room 200. Cory ...Charles Allen Thomas Professor of Chemistry, Chair and Professor of Chemistry. John . HeemstraCory Berkland. The University of Kansas. Verified email at ku.edu. Drug Delivery Formulation Controlled Release. Articles Cited by Public access Co ... YY Lin, M Laird Forrest, CJ Berkland. Expert opinion on drug delivery 6 (11), 1175-1194, 2009. 461: 2009: Fabrication of PLG microspheres with precisely controlled and monodisperse size ...Instagram:https://instagram. jtv mistymee jun chop sueywhat is a skinwalkers weaknessku med visiting hours Cory Berkland. Connect About Experience Recommendations. Saint Louis, Missouri, United States. Interested in Entrepreneur Technologically Savvy. Orbis Biosciences - Aquired by Adare Pharmaceuticals in 2020 Savara Pharmaceuticals - NASDAQ listed in 2017. Experience. david mccullarboise's craigslist Cory Berkland Solon E. Summerfield Distinguished Professor Department of Pharmaceutical Chemistry Contact Info [email protected] 785-864-1455 Multidisciplinary Research Building, Room 320E 2030 Becker Drive Lawrence, KS 66047 Personal Links Cory Berkland Research Education — Ph.D. in Chemical and Biomolecular Engineering, University of IlliniosSingkome Tima; Siriporn Okonogi; Chadarat Ampasavate; Chad Pickens; Cory Berkland; Songyot Anuchapreeda: 18-Jul-2015: HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth: Ornchuma Naksuriya; Yang Shi; Cornelus F. Van Nostrum; Songyot Anuchapreeda; Wim E. Hennink; Siriporn Okonogi wood that sinks in water nyt crossword Cory Berkland Date Defended: 11 July 2019. ii The thesis committee for Hao Lou certifies that this is the approved version of the following thesis: The Application of Machine Learning Algorithms in Understanding the Effect of Core/Shell Technique on Improving Powder CompactabilityMar 30, 2021 · Our clinical studies will determine if BBI-001 can reduce or eliminate the need for lifelong phlebotomies in Hereditary Hemochromatosis patients,” said Dr. Cory Berkland, Bond’s CEO, Chairman ... Amir Fakhari1 and Cory Berkland1,2,3,* 1Bioengineering Graduate Program, University of Kansas 2Department of Pharmaceutical Chemistry, School of Pharmacy, ... [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our